Connect with us

Technology

Seven Tips For Mastering Marketing On Facebook

mm

Published

on

In June, Facebook CEO, Mark Zuckerberg, claimed that more than two billion people now use the social network every month.

Facebook continues to grow at a spectacular rate and is the most popular social media platform. Due to this, Facebook has become a vital tool for marketing. Facebook marketing can target new customers and increase brand loyalty. However, in order to create a successful Facebook campaign, one needs to provide contents that are unique, creative and engaging.

Facebook marketing is essential for both small and large businesses. It helps them effectively and efficiently promote their brand online.

While running a Facebook marketing campaign, one must consider the following seven tips to convert your target audience to customers.

1. Choose the right images for your campaign and obey the rule of 20% image text: Images are essential in creating a Facebook Ad. However, try to avoid stock photos as much as possible. Focus on images that your audience can easily relate to. But bear in mind, no matter the type of ad you want to create, your image needs to be visually appealing.

2. Keep you campaign short and simple: Make the title as attractive as possible, but do not make false claims. In cases where you cannot edit the title (like when advertising a Facebook page), you can enter the URL of the page and then edit the title. However, if you do this, you will get limited Facebook ad analytics. Keep this short and crisp. Always end this with a ‘call to action’. In terms of importance, this is less crucial than images and title. In terms of the entire description, the call to action is the most important part.

3. Run different campaigns for the same product/service: Instead of creating different ads and split testing them, create variations of ad that performs best, and change one element at a time. For example, take your best ad, make copies of it and change the headline of each version. You now have multiple ads that are identical, except for the headline that you can test. After you determine which ad gets the best response, make copies of it and test another element like description or image.

4. Your ad must be relevant: This is the most important factor for an ad to perform well. Your target audience must be able to relate to the ad. Only once your audience connects with the ad, will you gain the most from advertising on Facebook. Relevancy can be obtained in many ways and there are no set rules on ‘how to be relevant.’ You need to ask yourself if the majority of your audience will click on this ad? If the answer is yes, then your ad is relevant.

5. Be engaging with your audience: Don’t automate everything. If you want people to engage your Facebook campaign, you need to create highly engaging content that is simple. “Highly engaging” means the content is relevant to your audience and compels people to click on it. Your content should make people stop in their tracks. When your audience stops to read your content, they should feel encouraged to engage with it.

6. Follow the 80/20 rule for posts: Keep 20% of your campaign content relevant to the product or service of your business while 80% of the campaign content should be social, but relate to your business and the targeted audience.

7.    Use Geo-targeting: If you’re looking to connect with potential customers in a specific location, it’s a must-have to use geographic targeting. To find the right customer base for your brand, provide content to your desired audience and also generate leads, one needs to set up ad according to geographic target areas. – Written by Wale Bakare

Source: Google

Continue Reading
Advertisement
Comments

Technology

‘A Tweet Can Tank An Economy’

mm

Published

on

Many perspectives have been shared on influencer marketing, but very few from the brands themselves. What are its business imperatives and ROI?


In the heart of Sandton, Africa’s richest square mile, is Brittany Preece, a social media manager at Investec Bank.

As part of the Private Banking marketing team, Preece and her team have managed to successfully implement disruptive digital strategies to meet the growth objectives of the bank.

Traditionally, the role of marketing has been to support business objectives. Yet when companies experience financial difficulty, more often than not, marketing is seen to be the first in line on the chopping block. As a way of adapting to this reality, most marketing managers have had to look at cost-effective, yet creative, ways of achieving business impact.

READ MORE | How Cryptocurrency Scams Work

Social and digital media have given room for new ways businesses can engage and sell to their customers.

Increasingly gaining traction in South Africa is influencer marketing, an entirely new branch of the sales and marketing funnel which has seen brands leverage popular personalities on social media to promote their products and services online. Globally, the influencer marketing industry is forecast to be worth $5 billion to $10 billion by 2020, according to a study by Mediakix.

For Investec, attracting and diversifying into new markets has informed their decision to leverage influencers as part of their marketing strategy.

“Since 2015, we as Investec, have predominantly used influencer marketing to reach the young professional audience,” Preece says.

READ MORE | Google, Facebook, Twitter Fail To Live Up To Fake News Pledge

“We (Investec Private Bank) have recently evolved our qualifying criteria. We’re no longer just the preferred banking partner for accountants, engineers, lawyers, doctors and actuaries. We’re positioned to be the bank of choice for those who are under the age of 30, consistently earning more than R600,000 ($42,582)a year, with a university degree and working in their area of expertise.”

Seated in front of a glass wall which looks out to a view of a bustling and upbeat office environment, she elaborates that to effectively reach the young professionals’ target market, it is important to identify individuals that can speak to that audience.

“What influencer marketing gives you, that a lot of the other marketing channels can’t, is great reach and engagement with your target audience. Using [influencers] brings a lot of authenticity to the brand, where Investec Private Banking was seen as unattainable to a lot of young professionals,” Preece says.

READ MORE | Facebook Recommits To A More Personalized Dating App, Your Privacy

In the digital universe, content is king. Authenticity is paramount. A study conducted by the Mobile Marketing Association reported that most consumers have banner blindness and suffer from advertising fatigue. They cannot recall the last digital banner ad that they saw.

Ad-blocking continues to be a growing phenomenon, further demonstrating the shift in consumer behavior. Consumers simply don’t want to be marketed to. To this effect, influencers assist brands to reach their customers through content that is more relevant to those consumers.

According to Business Insider’s 2018 Influencer Marketing Report: Research, Strategy & Platforms for Leveraging Social Media Influencers, the average social media engagement rate from influencer marketing averages 5.7% per post.

This is a feat compared to content generated by brands which fluctuates around 2% – 3% per post.

With this in mind, it’s even more essential for brands to involve influencers upfront to co-create an envisioned campaign.

“You want your influencer to buy into what you stand for as a brand. It shouldn’t be a hard sell – consumers see through that. If not done properly, it can look very fake and [we] never want to make it feel like an ad,” Preece says.

READ MORE | Crazy Aviators: The Eerie Similarities Between Billionaire Howard Hughes And Elon Musk

Brands and agencies measure awareness and engagement by analyzing a few parameters, including, inter alia, number of likes, comments, shares and followers. Proponents of this theory believe an increase in these parameters lead to brand success.

Detractors of the theory believe awareness and engagement alone are not sufficient indicators of brand success. “Likes and follows are unimpressive without an increase in the bottom line,” says Sinesipho Maninjwa, a financial analyst and commentator.

But technology has its limitations. Dianne Joseph, the Commercial Director of Digital at Nielsen, a leading global information, data and measurement company, elaborates that there are real challenges in measuring sales attribution as a result of influencer marketing.

“The influencer models are difficult to measure because most influencers use their own personal pages to post, and these organic posts don’t offer us the opportunity to implement a tag (for tracking purposes) and, therefore, we aren’t able to track the outcomes,” Joseph says.

The ability to measure what is happening on and off digital platforms, or across social media platforms, is a challenge that most digital marketers face. Different platforms such as Facebook and Twitter have their own unique methods of tracking and storing data. The link between these platforms is, therefore, a lot more tenuous.

But in support of influencer marketing, a number of global studies have come out and shown that influencer marketing does yield a positive return on investment (ROI).

Pierre Cassuto, of social media influencer platform Humanz, who recently set up shop in South Africa from Tel Aviv in Israel, believes that the use of influencers can lead to increased sales. “In the US market, there is about a four times ROI on money spent in the influencer marketing space for retailers, cosmetics and FMCG brands,” he adds.

Cassuto agrees that engagement on its own doesn’t yield conversion. For influencer marketing to yield conversion, the message being broadcast by influencers has to be well thought out and carefully constructed to achieve that objective.

There has to be a reason for someone to do something now as opposed to anytime. That can be around creating urgency around something specific, it can be around creating a limited time availability offer.

Essentially, brands can become creative and purposeful in how they design their entire campaign to track conversion from the ground up. “The way we suggest measuring conversion is by making sure that the influencers have a way that [brands] can track the relationship between the influencers post and the actual conversion,” Cassuto says.

The first looks at providing the influencer a coupon code that they can distribute and share. In doing so, the specific brands will know that the people who redeemed the coupon code came from the influencers. The second options measures sell over time related to increase in traffic due to influencer marketing towards a landing page that the brand is driving to. With this, Cassuto states that brands can do A/B testing to see the impact on days influencers are posting and days when they’re not.

With all the advantages of influencer marketing, should brands solely invest in this sales channel?

Preece firmly holds the view that influencer marketing on its own isn’t the be all and end all. “I do believe that it should be a mix. I believe that an integrated marketing plan that uses out-of-home, billboards, TV and digital is where you see the most results.”

“Things can go wrong with influencer marketing. You are putting faith and trust into a human being who is imperfect. We have a saying: A tweet can tank an economy,” Preece says.

With consumers becoming increasingly selective about what they consume, influencer marketing continues to grow as an attractive sales channel. It is imperative that brands place the necessary care and due diligence before partnering with any influencer.

The perfect fit between an influencer and the brand will determine the overall ROI. After all, effective influencer marketing is the online equivalent of the highly valuable word-of-mouth advertising that marketers have always coveted.

Continue Reading

Technology

Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself

mm

Published

on

By

hen Rachel Haurwitz started her biology Ph.D. at the University of California, Berkeley, the award-winning biochemist Jennifer Doudna suggested Haurwitz investigate part of a bacterial immune system. She studied how microbes store genetic mementos of attacking viruses and recognize them to fight off future assaults. “It was an esoteric project,” Haurwitz says. 

It’s esoteric no more. This system, called Crispr, has become one of the hottest technologies in biology, with the potential to give scientists control of the building blocks of life and give investors rich rewards. Crispr had no obvious relevance to human health when it was first described in 1987, but Doudna, who won the Breakthrough Prize in Life Sciences for her Crispr work, and other pioneers have discovered ways to turn it into a gene-editing tool. Haurwitz and Doudna helped found Caribou Bio­sciences in 2011 to get in on the action. Haurwitz, still in her 20s, became CEO the next year. 

Haurwitz is not the only young entrepreneur who sees opportunity in gene editing. Doudna cofounded Mammoth Bio­sciences with some of her other doctoral students and two Stanford Ph.D.s. Trevor Martin, the company’s 30-year-old CEO, has raised $23 million from such investors as Apple CEO Tim Cook. In 2015, in Cambridge, Massachusetts, 29-year-old Luhan Yang founded eGenesis with her mentor, Harvard geneticist George Church, to use Crispr to help transplant pig organs into people. Omar Abudayyeh and Jonathan Gootenberg, also in their 20s, cofounded Sherlock Biosciences with another Crispr pioneer, 37-year-old Feng Zhang of the Broad Institute of MIT and Harvard.

“They may be young, but in both cases these are people at the top of their game scientifically,” Doudna says of her cofounders. “They’re fearless in all the right ways and very aware of the ethical challenges.”   

Given that no one had built a Crispr company until a few years ago, “there’s maybe more of an opportunity for people with nontraditional backgrounds,” Haurwitz says.

Crispr is an acronym for “clustered regularly interspaced short palindromic repeats.” It refers to the way bacteria store, in their genomes, snippets of viral DNA, like mug shots. Those markers are used to identify invaders that return, much as a human immune system uses telltale elements of a polio virus remembered from a vaccine.

If an invading virus matches a stored mug shot, enzymes associated with Crispr break the virus’ lethal DNA into harmless pieces. Doudna and others figured out how to use those enzymes to snip DNA at precise points in order to insert or modify genes. Thus does Crispr promise to make the expensive and buggy process of rewriting DNA easier, opening up new ways to treat dis­eases caused by genetic mutations, create cheaper diagnostic tests and engineer cells that kill cancer.

Eight years after its start in Berkeley, Caribou has raised $41 million and cut licensing deals—potentially worth hundreds of millions of dollars—with DuPont Pioneer, Novartis and others. It’s starting to develop medical therapies.

Haurwitz grew up in Austin, Texas, and earned a bachelor’s degree in biology at Harvard. She didn’t have a clear plan when she went on to UC Berkeley, but she thought she might later become a patent attorney. 

That thinking changed as her Ph.D. work got more exciting. Haurwitz and Doudna spent a lot of time talking about how they could repurpose Crispr for modifying genomes to cure disease. Program the naturally occurring Crispr system to cut the gene you want to modify, and it’s theoretically possible to use it to change the genetic code to either fix “misspellings” that cause illness or disrupt the production of an unwanted protein.

Caribou started out with the notion of making Crispr technology available for DNA editing in applications such as drug development, agriculture and basic biological research. Haurwitz’s cofounders didn’t want to leave academia and were “crazy enough to let a 26-year-old who had never worked for a company in her life take on the role of president and CEO,” she says. 

Haurwitz took a few business classes before getting her Ph.D., then pitched venture capitalists on funding a technology they didn’t really understand. Caribou was securing an exclusive license to some Crispr patents held by the University of California system and the University of Vienna. Still, “pretty much every VC we ­talked to kind of said, ‘Meh,’ ” Haurwitz remembers. This was 2012, and they thought she was overestimating Crispr’s potential. 

The papers that propelled Crispr into the limelight came the next year, and investor dollars and a wave of new companies quickly followed. Editas Medicine, cofounded by Sherlock’s Feng Zhang, raised $43 million to apply the technology to medical therapies. Next was Intellia Therapeutics, cofounded by Caribou, which raised $15 million in its 2014 launch. And Crispr Therapeutics, founded by Crispr pioneer Emmanuelle Charpentier, raised $89 million. The three went public in 2016 and now have a combined market capitalization of $3.8 billion.

Meanwhile, Haurwitz was being cold-called by plant-breeding and drug companies. DuPont led an $11 million investment in 2015. Caribou raised another $30 million the next year and has been able to sustain itself on that funding and payments from licensing and partnership deals.

Caribou licensed to Integrated DNA Technologies the right to sell biology researchers what they’d need for gene-editing experiments. Genus, an animal genetics firm, paid Caribou an undisclosed amount for the exclusive right to use its proprietary Crispr technology to engineer the genes of pigs and other livestock. Similarly, the Jackson Laboratory is paying Caribou to use Crispr to engineer new populations of research mice that model human diseases. 

Haurwitz will soon have to seek venture capital again, as Caribou has pivoted to drug development, which is expensive but potentially more lucrative. Her first focus: improve on existing cancer therapies that take patients’ immune cells and train them to attack cancer. Crispr, she says, could be used to edit the DNA of immune cells from healthy donors so that these cells could be given to any cancer patient. The company plans to start trials in humans next year. There’s competition, from Allogene Therapeutics and its partner Cellectis, which have a combined market cap of $3.9 billion.

Caribou is also developing a program in another buzzy area: the microbiome, or the many bacteria that inhabit all parts of the human body, particularly the gut. This time, investors know what Crispr is, and Haurwitz has already won some over. “She’s one of the few people that I’ve met in my life that is able to toggle between business talk and scientific talk in a heartbeat,” says Ambar Bhattacharyya, a Caribou investor at Maverick Ventures.

Beyond the competition, there is an intellectual property conflict. Overlapping patent claims from the University of California and the Broad Institute emerged for the foundational technology, which involves an enzyme called Cas9, used to cut DNA. A lawsuit between the institutions was decided in favor of the Broad, but the U.S. Patent Office has granted patents to both. UC’s patents claim broader rights than were demonstrated in its application, says Lisa Ouellette, a Stanford Law School professor, and could make them vulnerable to a legal challenge. (UC disagrees.)

Whoever owns the technology will command fat fees. Caribou might run trials related to a particular gene, but if other companies want to run trials related to other genes, they may have to approach Caribou, says Jacob Sherkow, a professor at New York Law School. “They’re going to have to pay handsomely.”

Legal battles aside, the new field risks public backlash. In November, Chinese scientist He Jiankui announced he’d used Crispr to tinker with the genomes of human embryos born as twin girls, thereby heightening pressure on ­Crispr scientists to consider the ethics of how they’re using the life-altering tech. Caribou’s license agreements include language to prevent its use on human embryos, Haurwitz says. 

Doudna says researchers need to vet the science of editing the genes of embryos, and then people need to discuss how to use it responsibly. “Are there real unmet medical needs that would require this kind of editing or not? I think that’s one question.”

Debate over the answer will shape Crispr’s path to commercialization, one that holds immense potential for its youthful founders—and the likelihood of yet more controversy and conflict.

-Michela Tindera;Forbes Staff

-Ellie Kincaid;Forbes Staff

Continue Reading

Technology

Jeff Bezos And Elon Musk Want To Get To The Moon—They Just Disagree On How To Get There

mm

Published

on

By

This Thursday, Jeff Bezos will make an announcement about his space company, Blue Origin. The image on the invitation sent to members of the press, a view of the Earth as seen from the Moon, suggests the Amazon founder will unveil  Blue Origin’s plans to send both robotic and human missions to the lunar surface, possibly with a NASA contract in hand.

If that’s the case, he won’t be alone. Aerospace contractor Lockheed Martin has already unveiled its lunar plans in partnership with NASA. And Elon Musk’s SpaceX has a plan for a lunar flyby mission, while NASA Administrator Jim Bridenstein suggested to a Senate committee in March that the agency was open to using commercial heavy-lift rockets for its lunar crewed missions. SpaceX’s Falcon Heavy could serve such a mission.

The last few years have seen an increasing interest in going back to the Moon. The Trump Administration has announced it wants NASA to put humans back on the Moon by 2024, and the agency has also announced plans for a “Lunar Gateway” – a space station orbiting the Moon that would be developed in collaboration with multiple space agencies.  That space station brings with it opportunities for commercial companies to develop lunar capabilities to provide support for missions at the Gateway.

Lockheed Martin has a long history with NASA and lunar exploration—it was one of the contractors on the Apollo missions. But billionaires Musk, who runs Tesla as well as SpaceX, and Bezos represent the burgeoning commercial space industry, and the paths the two respective men took to get to this point couldn’t be much different.

What the two companies have in common is that both are very much products of their founders’ visions. Jeff Bezos founded Blue Origin in 2000, just three years after Amazon’s IPO fed his fortune. Two years later, fresh off the sale of PayPal, Musk founded SpaceX with his own personal fortune.

It’s from there, however, that the paths of the companies diverged. For the next 15 years, Blue Origin barely made any noise, save for some controversy as Bezos bought up land in Texas to serve as the company’s test facility in the early 2000s, and some small announcements about milestones it had achieved in agreements made with NASA for about $25.7 million in funding for space development. Bezos remains the sole owner of Blue Origin, and Forbes estimates that the world’s wealthiest man has funneled over $1.5 billion of his personal fortune into the company, financed by sales of Amazon stock.

Time-lapsed photo of SpaceX Falcon 9 launch
Time-lapsed photo of SpaceX Falcon 9 launchSPACEX

SpaceX, in the meantime, has been anything but quiet. The company began making noise in December 2003, when it drove its first rocket, the Falcon One, from the company’s headquarters in Hawthorne, California to Washington, D.C. in order to unveil it at the National Mall for an invited group of Congressional staffers, NASA and FAA officials.. Musk regularly promotes the company and its plans for the future, his eyes firmly set on Musk’s personal vision that SpaceX is to be the vanguard of humans becoming a multiplanetary civilization.

Musk was also more aggressive in obtaining venture financing and government contracts in order to support his company. Though he still maintains majority ownership (Forbes estimates his stake in the company is over 50%), SpaceX has also raised over $2.5 billion to date in venture financing, grants and debt, with a current valuation of over $31.5 billion, according to Pitchbook. Recent SEC filings show it aims to raise another $500 million in capital this year.

Throughout the past decade, SpaceX has kept itself in the public eye —even as it has brought the “move fast and break things” ethos of Silicon Valley to the traditionally more conservative aerospace industry.

“SpaceX is off trying new things, rapidly innovating, breaking things,” said Chad Anderson, founder of Space Angels, a VC firm specializing in the space industry.  “They test quite a bit, and we’ve seen some failures. We’ve seen explosions of rockets — they even put a highlight reel together of rockets exploding as they tried to land them. They take it as a point of pride that they’re willing to try new things and they’re really captured the imagination of the public that way.”

By contrast, Blue Origin rarely makes major announcements about future plans, unless it’s unavoidable due to public contracts or other reasons, preferring instead to focus its press efforts on what it’s accomplished. “Bezos proudly proclaims whenever he does a big announcement, he likes to talk about the things that he’s done,” said Anderson. One rare exception for this has been its plans for the Moon. Its robotic cargo delivery lander, Blue Moon, was first announced in 2017, and last summer the company revealed that it had a five year plan to get to the Moon.

While SpaceX has adopted a high-profile view of its risky, iterative innovation strategy, Blue Origin’s development is nearly the exact opposite. The company motto is Gradatim Ferociter, a Latin phrase meaning Step By Step, Ferociously. In interviews, Bezos has quoted the old military maxim that “slow is smooth and smooth is fast,” and every time one of its resuable rockets has a successful launch and landing, a tortoise is painted on its side, a nod to Aesop’s moral that “slow and steady wins the race.”

Despite Bezos’ faith in a more slow-paced, perfectionist approach to development, it’s undeniable that SpaceX has seen more success – at least so far. Though Blue Origin has had 11 successful launches to date, it has yet to send any spacecraft to orbit, instead keeping its launches suborbital, like the Mercury spacecraft that its current system is inspired by.

SpaceX, meanwhile, has had over 70 successful commercial orbital launches, which include not only putting satellites in orbit but also 15 successful deliveries of cargo to the International Space Station. It was the first company to make a cargo delivery to the station, and the company has also seen two successful launches of its Falcon Heavy rocket, currently the most powerful rocket in commercial production.

This track record has also come at some cost to the company. It’s had multiple launch failures, some of which have resulted in the loss of customer payloads, and more recently, a test fire of rockets on the spacecraft it’s developing to deliver astronauts to the space station led to the destruction of that craft— and has also likely pushed the schedule for sending astronauts to the station back to 2020. The company was originally set to have its first successful crewed flight in 2017.

In this billionaire race to the Moon, Bezos and Musk have set themselves up as the Tortoise and the Hare, respectively. But it likely won’t be until at least the mid-2020s that we learn which approach will win.

-Alex Knapp; Forbes Staff

Continue Reading

Trending